Peptide questions · Exenatide
How long does exenatide take to work?
Reviewed Evidence: EstablishedPublished by PepVault
Exenatide’s onset is first dose (after-meal glucose), its peak effect comes at 24–30 weeks (HbA1c), and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).
The timeline’s basis: FDA Byetta label (DailyMed, effective September 2025); Drugs@FDA marketing status (read November 2026); Eng 1992; DeFronzo 2005; EXSCEL (Holman 2017); Exenatide-PD3 (Vijiaratnam 2025). Approved for type 2 diabetes, not weight management.
Exenatide week by week
The library places four of its research notes on exenatide on the days they cover, from day 1 to day 180 and on: 3 on randomized trials and 1 on clinical data.
Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.
| When | The note | Evidence |
|---|---|---|
| Days 1–30 (weeks 1–5) | The 5 mcg start, before two meals | Randomized trial |
| Days 1–60 (weeks 1–9) | Why the shot comes before the meal | Clinical data |
| Days 31–180 (weeks 5–26) | 10 mcg, the full dose | Randomized trial |
| From day 181 on | A medicine the market moved past | Randomized trial |

Model. Individual results vary.
The exenatide timeline’s milestones
The library’s timeline for exenatide marks 6 points from week 1 to week 30, backed by clinical trial data overall.
- Week 1: Commonly reported: nausea and a smaller appetite around meals in the first days on 5 mcg
- Week 2: Each shot lowers the glucose rise of the meal that follows; levels are gone about 10 hours later (label)
- Week 4: The label allows the step from 5 to 10 mcg twice daily after 1 month, by response
- Week 8: Commonly reported: nausea eases for most people as the weeks go on, which the label also describes
- Week 24: In its 24-week trial, HbA1c fell 0.9 points on 10 mcg against 0.2 on placebo
- Week 30: In its 30-week metformin trial, weight fell 2.8 kg on average on 10 mcg
The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.
Why exenatide takes that long
Exenatide’s half-life is about 2.4 hours, so one dose is about 96.9% cleared after 12 hours.
On its schedule (Twice daily SubQ, before meals) the doses overlap, and the level of exenatide keeps climbing for about 9.6–12 hours before it levels off, so the first 9.6–12 hours run below the level the later weeks hold.
The notes on exenatide follow the trials’ dose steps, 5mcg and 10mcg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.
Exenatide against other metabolic & GLP-1 compounds
The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, exenatide among them; none of the others shares its onset of first dose (after-meal glucose).
| Compound | Onset | Peak effect |
|---|---|---|
| Semaglutide | Days–2 weeks | 60–68 weeks |
| Tirzepatide | Days–2 weeks | 72+ weeks |
| Retatrutide | Days–2 weeks | 48+ weeks |
| Dulaglutide | Days–2 weeks | 24–52 weeks (glucose) |
| Exenatide | First dose (after-meal glucose) | 24–30 weeks (HbA1c) |
| Setmelanotide | 1–2 weeks (hunger) | 52 weeks (BMI) |
| Orforglipron | Days–2 weeks | 72 weeks (trial endpoint) |
| Survodutide | Days–2 weeks | 76 weeks (trial endpoint) |
| Mazdutide | Days–2 weeks | 48–60 weeks |
| Pemvidutide | Days–2 weeks | 48+ weeks |
| Cagrilintide | Days–2 weeks | 26–68 weeks (trial endpoints) |
| Pramlintide | First meal (fullness, after-meal glucose) | 16–52 weeks (weight, HbA1c) |
| CagriSema | Days–2 weeks | 68+ weeks |
| Eloralintide | Days–2 weeks | 48 weeks (phase 2 endpoint) |
| Petrelintide | Days–2 weeks | 42 weeks (phase 2, still falling) |
| Amycretin | Days–2 weeks | 36 weeks (longest trial so far) |
| VK2735 | Days–2 weeks | 78 weeks (phase 3 endpoint, not yet read out) |
| Enicepatide | Days–2 weeks | 48 weeks (phase 2 endpoint, no plateau) |
| Ecnoglutide | Days–2 weeks | 48 weeks (phase 3, no plateau) |
| Efinopegdutide | Weeks | 24–52 weeks (trial endpoints) |
| SLU-PP-332 | Unknown in people | Unknown in people |
Questions people ask
How long does exenatide take to work?
Exenatide’s onset is first dose (after-meal glucose), its peak effect comes at 24–30 weeks (HbA1c), and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).
When does exenatide reach its peak effect?
By the library’s timeline, exenatide’s peak effect comes at 24–30 weeks (HbA1c), backed by clinical trial data.
How long is exenatide usually run?
The library’s timeline gives exenatide’s typical duration as ongoing; its cycle note says: FDA-approved for ongoing use in type 2 diabetes; the label's trials ran 16 to 30 weeks, with open-label extensions to 52 weeks.
What does the library say about the first days on exenatide?
Its first note on exenatide, for days 1–30 (weeks 1–5), is “The 5 mcg start, before two meals”, resting on randomized trials.